ATI 355 (C5 - T12) / 4-14 days after injury

Nogo antibody (also called ATI355 or IN-1).

Trial can be joined between 4 and 14 days after injury 
 
Countries: Canada, Germany and Switzerland
 
Asia A*: Complete injury

Neurological level: C5 to T12

Company: Novartis

A 4 Dose Regimens of Continuous Intrathecal ATI355 Infusion

Status: Phase I (Phase II trial is currently in preparation)

For more information click here.

* ASIA A indicates a "complete" spinal cord injury where no motor or sensory function is preserved in the sacral segments S4-S5.